Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

NCT07049341 is registered in ClinicalTrials.gov with NeuroEM Therapeutics, Inc. as lead sponsor.

NCT NCT07049341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07049341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
Lead sponsor
NeuroEM Therapeutics, Inc.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 31, 2025
Completion date
June 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, cortico basal degeneration, fronto-temporal dementia, neurological diseases or conditions, parkinson disease (pd), posterior cortical atrophy (pca)